The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Webcast
Part 3 of the GPO or Local/Self Contracting webcast series examines whether compliance can be achieved without alignment, and vice versa.
On-Demand Educational Webinars
At Hershey Penn State Medical Center, the supply chain and ED nursing team came together in a Kaizen process to reinvent the way supplies were being…
Webcast
The intersection of CQO is patient care, Deborah Rey presents ten commandments you should adopt if they're not already part of your values both…
Webcast
Panelists in Part 4 of the GPO or Local/Self Contracting webcast series focus on what providers should expect from their GPO partners. In a Part 5…
On-Demand Educational Webinars
On-site supply storage is one of the core competencies of effective supply chain management, and adhering to standards and regulations is an ongoing…